These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18374401)

  • 1. Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
    Li AJ; Scoles DR; Armstrong KU; Karlan BY
    Gynecol Oncol; 2008 May; 109(2):220-5. PubMed ID: 18374401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biology.
    Li AJ; Elmore RG; Pavelka JC; Karlan BY
    Gynecol Oncol; 2007 Dec; 107(3):420-3. PubMed ID: 17825390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.
    Li AJ; McAllister P; Karlan BY
    Gynecol Oncol; 2010 Jan; 116(1):105-8. PubMed ID: 19818997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen mediation of thrombocytosis in epithelial ovarian cancer biology.
    Li AJ; Karlan BY
    Clin Cancer Res; 2005 Nov; 11(22):8015-8. PubMed ID: 16299230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma.
    Li AJ; Baldwin RL; Karlan BY
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3667-73. PubMed ID: 14506156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mosaicism of androgen receptor CAG repeats in colorectal carcinoma epithelial cells from men.
    Di Fabio F; Alvarado C; Gologan A; Youssef E; Voda L; Mitmaker E; Beitel LK; Gordon PH; Trifiro M
    J Surg Res; 2009 Jun; 154(1):38-44. PubMed ID: 19062046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shorter CAG repeat length in the AR gene is associated with poor outcome in head and neck cancer.
    Rosa FE; dos Santos RM; Poli-Frederico RC; Canevari Rde A; Nishimoto IN; Magrin J; Rainho CA; Kowalski LP; Rogatto SR
    Arch Oral Biol; 2007 Aug; 52(8):732-9. PubMed ID: 17321486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a short CAG (glutamine) repeat on human androgen receptor function.
    Ding D; Xu L; Menon M; Reddy GP; Barrack ER
    Prostate; 2004 Jan; 58(1):23-32. PubMed ID: 14673949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor gene cytosine, adenine, and guanine trinucleotide repeats in patients with endometriosis.
    Lattuada D; Viganò P; Somigliana E; Odorizzi MP; Vignali M; Di Blasio AM
    J Soc Gynecol Investig; 2004 May; 11(4):237-40. PubMed ID: 15120698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor gene methylation and exon one CAG repeat length in ovarian cancer: differences from breast cancer.
    Kassim S; Zoheiry NM; Hamed WM; Going JJ; Craft JA
    IUBMB Life; 2004 Jul; 56(7):417-26. PubMed ID: 15545219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.
    Santarosa M; Bidoli E; Gallo A; Steffan A; Boiocchi M; Viel A
    Oncol Rep; 2002; 9(3):639-44. PubMed ID: 11956643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action.
    Ding D; Xu L; Menon M; Reddy GP; Barrack ER
    Prostate; 2005 Feb; 62(2):133-9. PubMed ID: 15389799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Mukherjee B; Mayer D
    Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.
    Dagan E; Friedman E; Paperna T; Carmi N; Gershoni-Baruch R
    Eur J Hum Genet; 2002 Nov; 10(11):724-8. PubMed ID: 12404104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic Cytosine-Adenine-Guanine Repeat Length of Androgen Receptor Gene and Gender Incongruence in Trans Women: A Systematic Review and Meta-Analysis of Case-Control Studies.
    D'Andrea S; Pallotti F; Senofonte G; Castellini C; Paoli D; Lombardo F; Lenzi A; Francavilla S; Francavilla F; Barbonetti A
    J Sex Med; 2020 Mar; 17(3):543-550. PubMed ID: 31926901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation.
    Léotoing L; Manin M; Monté D; Baron S; Communal Y; Lours C; Veyssière G; Morel L; Beaudoin C
    J Mol Endocrinol; 2007 Aug; 39(2):151-62. PubMed ID: 17693613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor gene CAG length polymorphism in women with polycystic ovary syndrome.
    Jääskeläinen J; Korhonen S; Voutilainen R; Hippeläinen M; Heinonen S
    Fertil Steril; 2005 Jun; 83(6):1724-8. PubMed ID: 15950642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women.
    Brum IS; Spritzer PM; Paris F; Maturana MA; Audran F; Sultan C
    J Soc Gynecol Investig; 2005 Feb; 12(2):135-41. PubMed ID: 15695110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer CAG repeat length in the androgen receptor gene is associated with premature ovarian failure.
    Chatterjee S; Singh R; Kadam S; Maitra A; Thangaraj K; Meherji P; Modi D
    Hum Reprod; 2009 Dec; 24(12):3230-5. PubMed ID: 19684044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.
    Ludwig AH; Murawska M; Panek G; Timorek A; Kupryjanczyk J
    Endocr Relat Cancer; 2009 Sep; 16(3):1005-16. PubMed ID: 19458022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.